-53%

est. 2Y upside i

Series A

Canix makes it easy to get and stay compliant as a cannabis business.

Rank

#770

Sector

Cannabis ERP Software

Est. Liquidity

~3Y

Data Quality

Data: Low

Canix presents a strong equity opportunity driven by its market leadership in the rapidly growing cannabis ERP sector, strengthened by its recent acquisition of Trym and innovative product launches.

Last updated: March 10, 2026

Bull (30%)+250%

Canix consolidates its market leadership through successful integration of Trym and strong adoption of its marketplace and payment features, reaching $70M+ ARR by 2028. This growth, coupled with a favorable regulatory environment for cannabis, drives a valuation of $500M+ at a 7x+ revenue multiple, leading to a significant Series B or acquisition.

Base (50%)+75%

Canix continues to grow steadily, leveraging its strong compliance integrations and expanded ERP capabilities. It achieves $40M+ ARR by 2028, maintaining its competitive position against specialized rivals. This performance supports a valuation of $250M-$300M, leading to a modest Series B or acquisition.

Bear (20%)-70%

Slower-than-expected cannabis market growth, increased competition from well-funded rivals, or challenges in integrating Trym lead to revenue stagnation. Canix reaches only $20M ARR by 2028, and a down round or unfavorable exit at $50M-$70M significantly diminishes common stock value due to investor preferences.

Est. time to liquidity~3.0 years

Preference Stack Risk

moderate

Investors hold $10.1M in liquidation preferences, meaning in an exit at or below this amount, common shareholders would receive little to nothing. At the estimated $150M current valuation, this represents 6.73% of the company's value.

Dilution Risk

moderate

As a Series A company, Canix will likely require additional funding rounds, which will lead to further dilution for existing equity holders.

Secondary Liquidity

none

Given the company's stage and size, there is currently no active secondary market for Canix equity.

Questions to Ask at the Interview

Strategic questions based on Canix's data — designed to show you've done your homework.

  • 1

    “How is Canix planning to further leverage the acquisition of Trym to differentiate itself from competitors like Distru and GrowFlow, especially in terms of advanced cultivation intelligence and operational efficiencies?”

  • 2

    “With the cannabis ERP market projected to reach $10.2B by 2031 and Canix's recent marketplace feature growing 800%, what are the key strategic initiatives to capture a larger share of this expanding market and scale revenue beyond the current $10M-$25M range?”

  • 3

    “Given the Series A funding in 2022 and the recent acquisition, what is the anticipated timeline for the next funding round or a potential liquidity event, and how does the company plan to manage employee equity dilution?”

Community

Valuation Sentiment

Our model estimates -53% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.